Mesoblast (MESO) Operating Expenses (2015 - 2023)

Mesoblast (MESO) has 9 years of Operating Expenses data on file, last reported at $59.2 million in Q2 2023.

• For the quarter ending Q2 2023, Operating Expenses rose 45.64% year-over-year to $59.2 million; the trailing twelve-month figure through Dec 2024 stood at $59.2 million (down 1.79% YoY), and the FY2025 full-year result was $74.1 million, up 14.56% from the prior year.
• Operating Expenses advanced to $59.2 million in Q2 2023, from $3.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $99.0 million in Q2 2021 to a low of -$19.3 million in Q3 2020.
• A 5-year average of $10.1 million and a median of -$3.1 million in 2021 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 949.23% in 2020, while the deepest fall reached 218.28% in 2020.
• Tracing MESO's Operating Expenses over 5 years: stood at -$14.2 million in 2019, then fell by 0.59% to -$14.2 million in 2020, then jumped by 74.38% to -$3.6 million in 2021, then surged by 44.24% to -$2.0 million in 2022, then soared by 3009.83% to $59.2 million in 2023.
• Business Quant data shows MESO's Operating Expenses at $59.2 million in Q2 2023, $3.1 million in Q1 2023, and -$2.0 million in Q4 2022.